Isotechnika Cleared by FDA to Commence Phase 3 Voclosporin TrialPharmaLive.com (press release)The primary endpoint of the trial will be defined as non-inferiority in biopsy proven acute rejection, or BPAR, episodes with patients receiving voclosporin f…
Telegraph.co.ukMore new drugs a bad fit with grapefruitKFVSOrgan transplant rejection drugs, such as cyclosporine (Sandimmune and Neoral),. Certain cardiovascular drugs, such as amiodarone (Cordarone and Nexterone), clopidogrel and apixaban. Because pe…
Orgenesis Appoints Leading Diabetes Expert, Camillo Ricordi, M.D., to …4-tradersThe Company believes that converting the diabetic patient's own tissue into insulin-producing cells overcomes the problem of donor shortage and removes the risk of tr…
Everolimus shrinks astrocytoma brain tumorsOncology Nurse AdvisorIn addition to helping prevent transplant rejection, everolimus is used in the treatment of renal cell carcinoma as well as SEGA. The FDA granted accelerated approval to everolimus for th…
Change text size for the storyLondon Free PressDrugs that can interact badly with grapefruit include cholesterol-lowering statins such as Zocor or Lipitor, blood pressure-lowering drugs such as Nifediac and Afeditab, certain organ transplant rejection …
Telegraph.co.ukDocs warn of mixing grapefruit and drugsToronto Sun… doses of the drug. Drugs that can interact badly with grapefruit include cholesterol-lowering statin drugs such as Zocor or Lipitor, blood pressure-lowering drugs such as Nifediac an…
ISOTECHNIKA PHARMA INC : 26 Nov 2012 – Isotechnika Cleared by FDA to …4-tradersThe primary endpoint of the trial will be defined as non-inferiority in biopsy proven acute rejection, or BPAR, episodes with patients receiving voclosporin for six months…
Isotechnika: FDA Oks To Begin Phase 3 Kidney Transplant Trials For VoclosporinNASDAQThe primary endpoint of the trial will be defined as non-inferiority in biopsy proven acute rejection, or BPAR, episodes with patients receiving voclosporin for six mon…
Isotechnika: FDA Oks To Begin Phase 3 Kidney Transplant Trials For VoclosporinRTT NewsThe primary endpoint of the trial will be defined as non-inferiority in biopsy proven acute rejection, or BPAR, episodes with patients receiving voclosporin for six m…
Isotechnika Cleared by FDA to Commence Phase 3 Voclosporin TrialEquities.comThe primary endpoint of the trial will be defined as non-inferiority in biopsy proven acute rejection, or BPAR, episodes with patients receiving voclosporin for six months as c…